|
|||||
|
|
Reply: Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States |
|
| Authors: | Catherine Saint-Laurent Thibault Divya Moorjaney Michael L Ganz Bruce Sill Shalini Hede Yong Yuan |
| Institution: | 1. Evidera, Montreal, QC, Canada;2. QuickPivot, Boston, MA, USA;3. Evidera, Waltham, MA, USA;4. Bristol-Myers Squibb, Hartford, CT, USA;5. Bristol-Myers Squibb, Plainsboro, NJ, USA |
| Abstract: | |
| Keywords: | |